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from the 18th to early 20th century in burn care, such as the 
recognition of  the importance of  burn surface area and skin 
grafting by Reverdin.[2] However, this was not reflected in 
improving survival and many patients still died of  shock and 
infection. It was not until the past 50 years that the mortal-
ity of  burns has been dramatically improved, thanks to the 
better understanding of the patho-physiology of burn injury.
The treatment of  burns is a major undertaking and involves 
many components from the initial first aid, assessment 
of  the burn size and depth, fluid resuscitation, wound 
excision, grafting and coverage, infection control and 
nutritional support. Progress in each of  these areas has 
contributed significantly to the overall enhanced survival 
of  burn victims and this article aims to explore the his-
tory of  burns to identify milestones and step-changes in 
each of  these areas in the patient’s care. As in the case of  
the advancement in the treatment of  trauma, these step-
changes were mainly related to wars. Napoleon’s surgeon’s 
Introduction
Burn injuries are amongst one of  the most devastating of  
all injuries, having a great impact on the patients physically, 
physiologically and psychologically. Burns are still one 
of  the top causes of  death and disability in the world.[1]
Physicians have searched for and formulated a myriad of  
treatments for burns over the centuries but these treatments 
mostly were of  little benefit to the victims mainly because 
the fundamental understanding of  the patho-physiological 
impact of  burns was not known yet. There was an expo-
nential increase in biomedical research and knowledge 
A B S T R A C T
Burn injuries are one of the most common and devastating aﬄ  ictions on the human body. In this article we look back at how the 
treatment of burns has evolved over the centuries from a primarily topical therapy consisting of weird and wonderful topical con-
coctions in ancient times to one that spans multiple scientifi c fi elds of topical therapy, antibiotics, fl uid resuscitation, skin excision 
and grafting, respiratory and metabolic care and nutrition. Most major advances in burn care occurred in the last 50 years, spurred 
on by wars and great fi res. The use of systemic antibiotics and topical silver therapy greatly reduced sepsis related mortality. This 
along with the advent of antiseptic surgical techniques, burn depth classifi cation and skin grafting allowed the excision and cover-
age of full-thickness burns which resulted in greatly improved survival rates. Advancements in the methods of assessing the surface 
area of burns paved way for more accurate fl uid resuscitation, minimising the eﬀ ects of shock and avoiding fl uid over-loading. The 
introduction of metabolic care, nutritional support and care of inhalational injuries further improved the outcome of burn patients. 
We also briefl y discuss some future directions in burn care such as the use of cell and pharmalogical therapies.
Key words: Burns, history, future, fi re disasters
Review Article
Burns & Trauma, October 2014, Vol 2, Issue 4





Lee, et al.: History of burns: The past, present and the future
Burns & Trauma • October 2014 • Vol 2 • Issue 4 170
contributions to wound management that are still appli-
cable today is an example. In burns, fire disasters as the 
Rialto fire in 1921 and Coconut Grove nightclubs fire in 
1942 led to research that provided the first glimpse of  the 
modern understanding of  the patho-physiology of  burns.
Ancient burn treatments
The majority of  ancient burn care consisted of  topical 
therapies and can be traced back to centuries. One of  the 
earliest records of  burn treatment was described in an 
Egyptian Smith Papyrus written in 1600 BC which advo-
cated the use of  resin and honey salve for treating burns,[3]
and the Ebers Papyrus in 1500 BC described the use of  
a wide variety of  substances to treat burn wounds.[4] In 
600 BC, Chinese described the use of  tea leave abstracts 
and tinctures for burns.[3] Many famous philosophers and 
physicians have contributed to burn wound management 
such as Hippocrates, who in 400 BC, described the use of  
bulky dressings impregnated with rendered pig fat and resin 
with alternated warm vinegar soaks, augmented with tan-
ning solutions made from oak bark[3] and in the 1st century 
AD, Celsus described the use of  wine and myrrh as a burn 
lotion, which had bacteriostatic properties.[3] The first de-
scription of  first aid for burns was around 854 CE-925 CE, 
by Muhammad ibn Zakariya al-Razi (or otherwise known 
as Rhases in the west), an Arabian physician who recom-
mended cold water for the relief  of  pain from burns.[5] A 
more recent example can be found in the 19th century, where 
a mixture of  linseed oil and lime-water (termed Carron oil) 
was being used to treat burns in Ironworkers in Scotland.[6]
With our current understanding of  microbiology and infec-
tion, it would be difficult to comprehend why faeces and 
excrement, rich in disease causing pathogens, was used in 
the open wounds caused by burn. The use of  a myriad of  
other different substances is interesting, however few of  
the ancient methods have any modern applications as they 
are unable to prevent bacterial infection which is one of  the 
major causes of  death of  burn victims (the exception being 
vinegar, first described by Hippocrates but which is now 
being rediscovered for its antibacterial properties especially 
in the treatment of  Pseudomonal infections).[7]
Treatment of infection in burns
Burn injury damages the skin which is the primary barrier 
to infection. Damaged skin that provides a fertile ground 
to bacterial growth, together with immunosuppression 
that accompanies major burns, are the main contributors 
to wound infection, invasive sepsis and if  not managed, 
death. With the advancement of  resuscitation methods in 
burn patients, deaths due to hypovolemia and hyperosmolar 
shock are now uncommon. Meanwhile, sepsis is now the 
commonest cause of  death following burn injury and con-
tributes to almost 75-85% of  all burn victim deaths.[8,9] Over 
the last few decades, many advancements have positively 
impacted on the incidence of  burn wound infections and 
these include, topical and systemic antimicrobial therapies, 
early burn wound excision and closure and the introduction 
of  infection control measures in modern burn units such 
as isolation facilities.
Systemic antibiotics
The discovery of  penicillin by the Scottish scientist, Sir 
Alexander Fleming in 1928 was a major breakthrough in 
the fight against microbial infections but it was not until 
World War II (WW2) that a way to manufacture the drug 
in large industrial scale was achieved. Penicillin played 
a crucial part in the treatment of  the burn victims of  the 
Coconut Grove fire in Boston in 1942, as it combated the 
Staphylococcus bacteria which typically led to toxic shock 
syndrome and also infected skin grafts. The emergence of  
methicillin-resistant staphylococcal strains however curbed 
the effectiveness of  natural penicillins as the penicillinase 
produced by these bacteria hydrolyse the penicillin B-lactam 
ring and render them ineffective which in turn necessitated 
the development of  penicillinase-resistant penicillins such 
as methicillin and cloxacillin. Streptococcal organisms are 
a major bane in the treatment of  burn injuries as even the 
presence of  a few B-hemolytic streptococci such as Group 
A (Streptococcus pyogenes) and Group B (Streptococcus agalac-
tiae) can lead to a wound infection, loss of  skin grafts and 
failure of  a primary wound closure. Fortunately, natural 
penicillins remain effective and are bactericidal to these 
bacteria. Although staphyloccocal and streptococcal infec-
tions remain a major problem in burns, the landscape of  
microbes in burns continues to evolve with the emergence 
of  antibiotic resistant strains e.g. the vancomycin-resistant 
enterococci (VRE) and Pseudomonas spp. which is now one 
of  the most repeatedly encountered wound pathogen and 
a leading cause of  noscomial infections in burn patients.
Topical therapies
The aim of  topical therapies has changed over the centuries 
as we understand increasingly more about the pathophysi-
ology of  burn wounds. In the early 20th century, the goal 
of  topical therapies was to prevent the release of  ‘toxins’ 
from the burn wound and to dry out the wound to allow 
formation of  a hard coagulum to minimize fluid loss. A 
variety of  therapies were developed to achieve this such 
as the tannic acid spray described by Davidson in 1925[10] 
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which was believed to produce a cleaner wound. However 
its use was stopped when it was found to be a hepatotoxic.[11]
One of  the first topical antimicrobial treatments discovered 
was sodium hypochlorite (NaClO) in the 18th century by 
Berthollet. Its use was hampered by irritation it caused,[12] but 
this was later discovered to be due to its variable quality and the 
free alkali or chlorine it contained. In 1915, Dr. Henry Dakin 
successfully developed a method of synthesizing hypochlorite 
without its irritating contaminants and found initially that 
a concentration of  0.5% was most effective as an antiseptic 
solution[13] (revised later to 0.025%[14]). This was further 
developed and used successfully in the treatment of  burn 
wounds with a protocol of  mechanical cleansing, surgical 
debridement and topical application of hypochlorite solution.
The major milestone in topical burn therapy was the ap-
plication of  solutions of  silver compounds or salts, which 
played an important role in reducing the rate of  burn wound 
sepsis and mortality. Silver sulfadiazine was developed by 
Charles Fox in the 1960’s[15] and has become the mainstay 
of  topical antimicrobial therapy due to its success in con-
trolling infection and minimal side effect profile. Mafenide 
acetate (Sulfamylon)[16] briefly was a viable alternative to 
the use of  silver compound solutions in the treatment of  
infections but due to its carbonic anhydrase inhibitory ef-
fects which can lead to systemic acidosis, its use was all but 
discontinued except in cases of  treatment of  invasive wound 
infections. The other common silver-based therapy was sil-
ver nitrate, described by Moyer et al. in 1965.[17] Silver based 
topical treatments were successful in controlling infections 
especially Pseudomonas aeroginosa infections.
Recent development in dressing technology have seen the use 
of a variety of interesting materials incorporated into the dress-
ing. There is emerging evidence for the use of dressings and 
gels[18-21] containing the naturally occurring glycosaminoglycan, 
chitin, which prevents early extension of burn injury[22], has 
antimicrobial properties,[23,24] promotes fibroblast proliferation 
and angiogenesis[25] and may promote burn wounds to heal, 
effects that are augmented by the incorporation of growth 
factors into the gel.[26,27] There has also been studies on the use 
of carbon fibre in dressings which has been shown to increase 
the absorptive capacity of the dressing, reduce inflammation, 
reduce bacterial growth and promote healing.[28,29]
Role of non-pharmalogical therapies
Although antibiotic treatment is a major front in the war 
against infection, non-pharmalogical interventions play 
equally important roles, such as strict handwashing and 
hygenic nursing standards and patient isolation. The need 
for strict burn patient isolation became an important issue 
after WW2. State of  the art burn centres were established 
in the United States then across the world. The Brooks 
Army center is an example of  facility that was designed 
with infection control and patient isolation in mind.
Surface area assessment in burns
It was only at the end of  the 19th century that it was realized 
that a relationship existed between the size of  a burn and 
mortality. An early attempt at linking the size of  burns to 
prognosis was carried out by Smart CB (1876) who studied 
12 burn victims from an explosion aboard a ship and con-
cluded that burn severity was determined by their size and 
depth, in addition to other bodily systems that were affected 
such as the airway.[30] Schjerning advanced this idea of  the 
relation of  mortality with burn size in 1884; he found that 
death always followed if  two thirds of  the body was burned, 
to be expected if  50% of the body was burned, and generally 
occurred if  a third of  the body was burned.[31]
However it was not until the late 18th to early 19th century 
was there any real attempt at accurately measuring burn size. 
Meeh in 1879 first described a method of using graph paper 
to measure burn body surface area (BSA).[32] Weidenfeld 
found this technique of measuring BSA too unwieldy and 
uncomfortable for the patients. By using his own and Meeh’s 
calculations, he discovered that there was a constant relation-
ship of the surface area of well-defined body regions such as 
the head or arm and the total BSA. Using this knowledge he 
was then able much more accurately to indicate the extent of a 
burn injury and subsequently was able to correlate the size of  
a burn and the time of early death. Additionally he also found 
that other factors such as age, depth of burn and the general 
health (constitution) of the patient also played a role.[33]
Berkow calculated the surface area of  various body parts in 
relation to the total body surface area, incorporating the use 
of  calculations of  body surface area as a function of  overall 
height and weight by Du Bois D and Du Bois EF.[34] Berkow 
recognised as well that his formula needed to be corrected 
if  used in children. Lund and Browder later modified this 
in 1944 by accurately defining the anatomical regions and 
dividing the BSA into 12 regions, as well as introducing an 
age correction factor for children based on a BSA calculations 
done by Boyd (1935) who in turn modified it from Du Bois D 
and Du Bois EF. The Lund and Browder chart is still widely 
used today. Notably, a Chinese scientist, Chu, estimated the 
bodily proportions in Chinese using a wet paper moulding 
method in 1982, however the differences between his findings 
and those of  Lund and Browder were only slight, further 
supporting the accuracy of  these two parallel methods.[35]
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Berkow’s method not only gave rise to the Lund Browder 
chart but is also credited with a simplified method of  as-
sessing BSA which is the Rule of  Nines. Wallace published 
details in 1951 of  this simplified method to measure burn 
BSA.[36] This method is also sometimes credited to Pulaski 
and Tennison (especially in the USA), who had presented 
a very similar idea first in a symposium in 1950 and later 
combined his ideas with Wallace. The rule of  nines esti-
mates the patient’s hand surface area (defined as the area 
enclosed by a line drawn around the patient’s hand with 
extended fingers) as 1% of  the BSA, although this has been 
shown as less than accurate.[37] However it has its place in 
the quick assessment of  small burns.
The assessment of  burn size is now a standard part of  the 
diagnostic and treatment process in terms of  fluid replace-
ment therapy and plays a role as a prognostic indicator.
Depth of burns classification
The first classification of  burn depth actually goes back 
to the 16th century. Guilhelmus Fabricus Hildanus, often 
regarded as the founder of  surgery in Germany, in 1634 
recognized the link between the length of  time heats acts 
on the body and the resulting damage.[38] He categorised 
it into three stages; the first stage was characterised by 
erythema and blisters with colorless fluid, the second 
stage by erythema and blisters with yellow fluid, and 
the third, most serious stage, by the lack of  blistering, 
and hard, dry skin that was blue or black and the lack of  
pain. Hildanus went on to publish De Combustionibus in 
1670, which discussed the pathophysiology of  burns and 
contributed to treatment of  contractures. The three stage 
method of  description was also utilized by Van Alberding 
in 1681, but he categorised it as light burns with blister-
ing, contraction of  the skin and thirdly, separation of  the 
skin and underlying flesh with crust and ulcer formation.
The practice of  classifying burns in ‘degrees’ was introduced 
in the 18th century. Two German surgeons, Heister (1724) 
and Richter (1788) classified burns into four degrees: 
• First degree: Heat, pain and small blisters.
• Second degree: Severe pain and large blisters.
• Third degree: Damage to the skin and underlying flesh, 
with crust formation.
• Fourth degree: Damage to all soft tissues down to the 
bone. 
In 19th century, Guillaume Dupuytren developed a 
classification of  burn depth after a review of  the care 
of  50 patients. This classification divided burns into the 
following six degrees:
• First degree: Erythema.
• Second degree: Skin inflammation with epidermal 
detachment.
• Third degree: Partial destruction of  the papillary layer 
and subpapillary network of  the corium.
• Fourth degree: Destruction of  the skin down to the 
subcuticular layer.
• Fifth degree: Crust formation over skin and muscle.
Dupuytren’s classification is still in use by some today.[39] 
However many modern writings tend to use a simpler three 
degree classification system and this may be attributed to 
a French surgeon, Boyer, and was introduced in the begin-
ning of  the 18th century (1814).[40] This classification divided 
burns into the following three degrees: 
• First degree: Erythema.
• Second degree: Blistering of  the skin leading to 
superficial ulceration. 
• Third degree: Tissue disorganization leading to a dry 
yellow crust.
The current convention for describing burns is using depth 
rather than degrees; that is superficial, mixed depth and 
full thickness and new techniques are now in development 
to help physicians determine the depth of  burns more ac-
curately and objectively. These include thermal imaging[41], 
the use of  laser techniques such as laser doppler imaging and 
laser speckle perfusion imaging[42] and also enhanced photo-
graphic methods which are aided by computer systems such 
as the spectrophotometric intracutaneous analysis scope.[43]
Fluid resuscitation
The need for fluid resuscitation in burn injured patients was 
first recognised by Underhill. When he studied the composi-
tion of  blister fluid of  patients injured in the Rialto Theatre 
fire in 1921,[44] he found that it was similar to that of  plasma 
and suggested that burn mortality may be due to loss of  fluid 
rather than toxins. The introduction of  methods of  accu-
rately quantifying burn surface area such as the Lund and 
Browder chart in 1944 and ‘rule of  nines’ by Wallace and 
Tennison led to fluid replacement strategies based on total 
body surface area burned. By the 1940’s, the link between 
a proportional relationship between the percentage body 
surface area burned and the volume of  fluid resuscitation 
required was established by Cope and Moore,[45] who were 
able to quantify the amount of  fluid per area needed for 
adequate resuscitation by studying young adult burn victims 
in the Coconut Grove Nightclub in Boston in 1942. Moore 
went on to develop a formula for calculating the amount 
of  replacement fluid required based on the percentage of  
body surface area burned.[46] Evans et al., in 1952 added to 
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this formula by including body weight in the calculations[47]
and Reiss modified Evans formula by substituting normal 
saline with Ringer’s lactate and reducing the amount of  
colloid given.[48] Colloid was altogether removed by Baxter 
and Shires,[49] whose formula is now commonly known as 
the Parkland formula for fluid resuscitation which is still 
widely used in current practice.[49]
The use of  colloidal solutions in the resuscitation of  burns 
has had varied proponents and opposition over the years. 
Rosenquvist was the first to publish the use of  dextran, a 
solution of  polysaccharides in physiological saline, in the 
treatment of  burn patients in 1947 and obtained good re-
sults with its use.[50] In 1962, Muir and Barclay proposed a 
formula of  resuscitation which centered on the provision of  
colloid in the form of  freeze dried plasma for resuscitation 
over a 36-hour period and this was used intensively in the 
United Kingdom (UK).[51] However Cochrane reviews in 
1998 and 2003 (lastest version published in 2013), showed 
that there was no evidence from randomized controlled 
trials that resuscitation with colloids reduces the risk of  
death compared with crystalloids in patients with burns 
and discouraged their use.[52]
Surgical interventions in burns
Early excision of burns
The idea of  excising burns existed in ancient times, in 
1510-1590 AD, 400 years ahead of  his time, Ambroise Pare, 
was one of  the first to describe early burn wound excision. 
In 1607, Hildanus also recommended removal of  incisions 
made into burn eschars to allow drainage of  serous fluid 
and allow better penetration of  medications. However the 
benefit of  surgical eschar removal was hampered by poor 
hygiene and lack of  antiseptic surgical techniques, which 
would lead to a high rate of  infection and blood loss. Ad-
ditionally, wound management was not fully understood. 
Therefore the practice of  early burn excision was rightly 
abandoned even though physicians recognized the im-
portance of  the early removal of  dead tissues to reduce 
the inflammatory response. Patients with full-thickness 
burns could only languish in hospitals while their eschars, 
which were invariably infected, sloughed off, leaving open 
wounds that heal by secondary intention with remarkable 
contractures and disabilities.
Significant advances in infection control made burn eschar 
excision possible, when Lister in 1865 started successfully 
utilising carbolic acid (or phenol) as a method to sterilise 
surgical instruments and clean wounds. This, along with 
advancements in topical infection control, led to a sig-
nificant decrease in post-operative infections and improved 
survival. On the other hand, the understanding and manage-
ment of  burn shock in the late 1950s was already underway. 
Improvements in the treatment of  shock such as improved 
fluid resuscitation techniques, blood volume monitoring 
and realisation of  the importance of  urine output measure-
ment allowed a greater efficiency of  burn shock treatment 
and consequently more patients survived the initial shock 
stage. This in turn allowed the excision of  full thickness 
burns to be more feasible and safe.
WW2 brought about a tremendous increase in burn vic-
tims, and physicians had to find a way to help patients 
recover faster. Physicians approached the problem of  full 
thickness burns initially by chemical debridement with 
pyruvic acid and starch, which allowed grafting as early as 
6 days post debridement.[53] Several other authors reported 
in the 1940s their successful attempts at surgical excision 
of  full thickness burns.[54-57] However most reports have 
been anecdotal.
In 1960, Jackson et al., published a series of  pilot and 
controlled trials which showed that excision and grafting 
(20-30% of  TBSA) could be safely achieved as long as 
shock was controlled via red cell volume monitoring[58] and 
recommended the technique in cases of  full-thickness burns 
(as natural slough separation would take 6 weeks), burns 
of  15-20% and deep circumferential burns of  the trunk 
which affect respiration. However due to small numbers, 
they could not conclusively demonstrate an impact of  the 
technique on mortality, infection nor healing time which 
probably prevented it from being accepted by the majority 
of  surgeons at the time. What probably changed practice 
was the introduction of  the tangential excision technique 
by Zora Janzekovic in the 1970s which was a significant 
improvement in the technique.[59] An important modifica-
tion introduced by this technique was that the excision not 
only included slough but also of  the damaged dermis down 
to bleeding tissues. Her technique was advocated by many, 
several (including herself)[59] who have reported improve-
ment in mortality and also decrease in hospital stay when 
compared with conservative treatment.[60,61] The technique 
became the standard of  care in most leading burn centres 
across the globe, but was only limited to small burns that 
could be covered by skin from patients’ own donor sites.
Wound cover after major burn excision was the challenge 
that delayed the practice till the 1970’s, when xenograft, 
pig skin, and cadaver skin became more widely available. 
Although Bettman reported success in the treatment of  
children with large full-thickness burn injuries with allograft 
skin in way back in 1938[62], modern day skin bank only 
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began following the establishment of  the United States 
Navy tissue bank in 1949.[63]
In the first publication of early burn excision of major burns, 
Tompkins et al., credited the introduction of  early exci-
sion and grafting of  large burns for the dramatic decrease 
in mortality in children from 24% to 27%.[64] Dr. David 
Herndon in a series of  landmark papers has demonstrated 
the benefit of  total early burn wound excisions for survival 
and improved outcomes.[61,64]
Skin grafting and the development of skin substitutes
The earliest record of  skin grafting goes back to the 5th
century AD, where an Indian surgeon, Sushrutha, repaired 
noses, that were amputated as punishment for crimes, us-
ing strips of  skin from the forehead which were flapped 
downwards and grafted over the wound[65,66]. Sushrutha has 
also been documented to transplant skin from the buttock 
to the nose. The first documentation of  a modern skin 
graft in humans was by Carl Bunger in 1823. This again 
involved a nose wound, and full thickness skin from the 
inner thigh was used for this purpose. During this time 
however, the success of  skin grafts was low due to inef-
ficient harvesting and use of  large and thick grafts. Free 
skin grafting was successfully reproduced by Reverdin, 
who was still a student at the time, in 1869 to encourage 
healing and closure of  slow healing or chronic wounds.[2]
Reverdin utilized “pinch grafts”, which were small circular 
skin discs obtained by pinching a small amount of  skin and 
cutting it out. This was done repeatedly to produce islands 
of  small grafts that were used to cover the wound, and it 
left donor sites that healed quickly due to their small sizes. 
This was soon popularized in England by George Pollock 
in 1870.[67] Advances in the quality of  surgical instruments 
meant that thinner grafts than previously possible could be 
harvested. Thiersch took advantage of  this and developed 
and advocated the use of  razor thin skin flaps or “razor 
flaps”[68] in 1874. However these grafts did not produce 
satisfactory results in general and were limited to the treat-
ment of  small ulcerated wounds. Seven years later, Girdner 
reported the first successful use of  allogeneic skin in burn 
wound coverage.[69]
In the 1920’s, Blair and Brown discovered that deep islands 
of  hair follicles and sebaceous gland epithelial cells were 
the factor responsible for initiating the healing at donor 
sites. This meant that grafts could be harvested to different 
depths as long as these islands were preserved. Tools that 
allowed the surgeon to control the depth of  skin harvested 
then quickly developed. Surgeons initially had to harvest 
thin grafts with the use of  blades that afforded no mecha-
nism to control graft thickness such as the Blair and Catlin 
knives.[70] Hofman and Finochietto developed knives that 
permitted precise regulation of  the thickness harvested via 
screw-adjusted knives.[71] Split thickness skin grafts (so called 
as the tools used to harvest these grafts resembled the tools 
used for splitting leather) however only started becoming 
more popular in the 1930s due in part to the development 
and availability of  more reliable instruments. Humby then 
developed a knife allowed control over the depth har-
vested[71] in 1936, followed by an adjustable dermatome by 
E.C Padgett in 1939.
The method of  meshing grafts can be traced back to Lanz 
in 1907, who designed a cutting tool consisting of  a series 
of  small knives mounted in parallel to make multiple 
holes in a graft, forming a mesh.[72] A method of  expand-
ing the graft size was described by Meek in 1958[73] which 
utilizes a special dermatome (Meek Wall dermatome) and 
prefolded gauzes which allowed a nine fold expansion of  
the harvested graft.[74] The Meek dermatome was however 
viewed as cumbersome and required much skill and was 
thus superseded in 1964 by the introduction of  simpler 
‘mesh dermatome’ developed by J.C. Tanner et al. which 
allowed a graft to be expanded three times the original donor 
site size.[75] The Meek technique has in recent years though 
been seeing a revival in its use including the development 
of  modified, air driven dermatome by Kreis et al., in 1994 
and has an advantage over mesh grafts when donor sites 
are limited e.g. in larger burn wounds.[76-78] Additionally, a 
study investigating the real expansion rate of  meshers and 
Meek micrografts showed the Meek technique provided 
more reliable and valid expansion rates compared to the 
skin meshers.[74,79]
Despite the introduction of  meshing and micrografting 
techniques, these were still insufficient to meet the increased 
demand for skin in cases of  large burns especially with the 
introduction of  the concept of  early total burn excision, 
and thus cryopreservation and long term storage of  human 
skin for both autologous and allogenic skin transplantation 
were developed in the 1940-50’s[80,81], of  which a major 
milestone was the introduction of  the use of  glycerol to 
cryopreserve skin.[82]
Skin allografts allowed the coverage of  burns in cases where 
there was extensive skin loss or where limited sources of  
sites for autograft harvesting were available and could be 
used with or without concurrent skin autografts. Jackson 
described a combined grafting technique[83] which utilized 
alternate placement of  narrow stripes of  allograft and au-
tograft onto a granulating or excised wound hence it was 
also known as ‘Tiger-striping’. Following the adherence of  
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the grafts, a process termed ‘creeping substitution’ occurs, 
whereby migration of  autologous epithelial cells occurs 
across the wound surface between the sheets of  autograft 
and underneath the allograft sheet causes the allograft sheet 
to slowly lift and separate, leaving an epithelized wound 
bed. This technique has been used and adapted by the 
Chinese surgeons, Zhang and co-workers,[84-86] who minced 
autologous skin into pieces less than 1 mm in diameter 
and then seed these ‘micrografts’, into the dermis of  large 
sheets of  allograft skin prior to applying it onto the wound. 
The autograft epidermal cells proliferate and migrate and 
eventually via the process of  creeping substitution, lifts and 
separates the allograft. While this method results in effective 
skin expansion ratios up to 1:18, it has been associated with 
severe wound contraction compared to sheet autografts.[87]
Currently, micrografting techniques including the Meek 
technique has been more widely adopted in China than 
any other country.
Unfortunately, allogenic skin transplants trigger a potent 
reaction and rejection by the host immune skin and are 
invariably rejected acutely and immunosuppressive treat-
ments that have proven effective in preventing rejection 
of  organ transplants have sadly little or no effect on skin 
transplants. Thus in the UK, the use of  allografts has been 
slowly phased out.
Another method of  wound cover had to be developed 
and in the 1970’s, Yannas, a scientist at the Massachu-
setts Institute of  Technology and Burke, a surgeon at 
the Massachusetts General Hospital and Shriners Burns 
center collaborated to develop and produce the first 
artificial skin, Integra®. It consisted of  two layers, a 
collagen-chondrotin matrix and a silicon layer on top. 
The first multicentered clinical trial was conducted and 
published in 1988[88] and was granted an FDA licence 
in 1996. Integra is now widely used in acute burns and 
reconstructive surgery. Other artificial skin substitutes 
include Apligraf, developed by Bell et al., and Matriderm 
by Otto Suwelack.[89]
Metabolic care and nutritional support
The catabolic response to injury has been noted as early 
as in the 18th century by Sir John Hunter, but the ‘ebb’ 
and ‘flow’ phases of  injury was first clearly documented 
by a Scottish nutritional scientist, David Cuthbertson in 
the early 1940s while he was studying the urinary excre-
tion of  minerals in facture patients.[90] The ‘ebb’ phase in 
burns (also known as the acute or shock phase) occurs 
within 48 h of  injury and is characterized by a decrease 
in the metabolic rate with depressed oxygen consumption, 
cardiac output and glucose tolerance.[91] If  patients survive 
this shock phase, they then go into the ‘flow’ or chronic 
response phase which is typically characterized by an 
elevated hyperdynamic state with increased metabolism 
and cardiac output.[91] This increased hypermetabolism 
is responsible for the highly catabolism seen in severe 
burn injuries with accelerated glycolysis, proteolysis, and 
lipolysis leading to weight loss and the erosion of  lean 
body mass (LBM), generalized fatigue and a weakened 
immune response.[92,93] The loss of  LBM has a particularly 
devastating effect on the outcome of  patients as Chang et 
al., has shown that impaired immunity is seen with 10% 
loss in LBM, decreased wound healing with 20% loss in 
LBM and death with 40% loss of  LBM.[94]
Several therapeutic strategies have been devised to 
ameliorate the hypermetabolic response including envi-
ronmental control, excision of  injured and dead tissue to 
reduce inflammatory stimulation, nutritional support and 
pharmacological therapies.
Only since the early 1900s has it been recognized that burn pa-
tients require an increased caloric intake. High caloric feeding 
was advocated by Shaffer et al. in 1909[95] and more recently by 
Wilmore in 1979.[96] An in-depth understanding of the impor-
tance of the nutrition support was only established in 1970s. 
A high protein and high calorie diet supplemented with multi-
vitamins and trace elements are required for burn patients. The 
evidence of other dietary supplements such as glutamine is 
not firmly established yet.[97-99] The route of feeding has been 
shown to be important as well. Herndon et al. showed that 
nutritional support, when given parentally, was shown to be 
harmful as it increased both immune deficiency and mortality 
and thus continuous enteral feeding is advocated instead.[100] 
A recent review of the evidence surrounding nutritional sup-
port for burns patients guided the recommendations made by 
the European Society for Clinical Nutrition and Metabolism 
(ESPEN), including the need for early enteral feeding via the 
nasojejunal or nasoduodenal route.[101]
In the last few decades, various pharmalogical interven-
tions have been trialled in burn patients, chiefly to attempt 
to reduce the hypermetabolic response. Examples include 
Propranolol (a B-receptor antagonist),[102,103] anabolic 
agents such as human recombinant growth hormone[104] 
and oxandrolone,[105] and anti-hyperglycaemic agents such 
as insulin[106,107] and metformin.[108]
The loss of  LBM can also be accomplished by early reha-
bilitation from day one after the injury with active rather 
than passive exercises, even with intubated patients, will 
preserve the LBM and reduce complications.
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Inhalation injury in burns
The interest in pulmonary function in burns patients prob-
ably started in the 1970s when physicans started to note 
that pulmonary complications were common in burn pa-
tients. With improvements in the treatment of  burn shock 
and sepsis, inhalational injury has now replaced these two 
causes as the main cause of  mortality in burn patients.[109]
Inhalational injury by itself  has been shown to be associ-
ated with pulmonary dysfunction for at least 6 months after 
the injury.[109]
Pulmonary complications in burn patients can arise from 
direct injury to the respiratory tract via the inhalation of  
heated air and chemicals released by combustion, and also 
iatrogenic factors such as fluid-overloading during resuscita-
tion and lung damage by mechanical ventilation.
Airway and pulmonary inflammation can also result from 
smoke inhalation alone. An autopsy study by Zikria et al., 
in 1972 showed that 70% of  all burn victims who died 
within 12 hours of  injury had inhalational injury which 
could be linked to the toxic products of  combustion.[110]
A study by Herndon et al., in 1985 using an experimental 
sheep model of  smoke inhalation injury showed that the 
pulmonary edema that occurred after smoke inhalation 
was the result of  an increase in microvascular permeability 
and hypothesized that this may be secondary to neutrophil 
degradation.[111] The global immunosuppression that ac-
companies burn injuries increases the risk of  developing 
respiratory tract infections.[112]
The treatment of  burns itself  can contribute to the develop-
ment of  lung injury. Moore et al., noted that although fluid 
resuscitation and blood transfusions prevented acute renal 
failure in trauma patients, these patients went on to develop 
pulmonary complications.[113] Pruitt et al., hypothesized 
that pulmonary insufficiency in burns patients was due 
to a complex mechanism of  interstitial edema leading to 
alveolar epithelial cell (type 2) damage and pulmonary cir-
culation constriction secondary to vasoactive substances.[114]
Achauer et al., proposed a number of  measures to prevent 
pulmonary edema including the use of  pulmonary artery 
wedge and central venous pressure monitoring and also the 
supplementation of  crystalloids with albumin to reduce the 
amount of  fluid required.[115] This was supported by animal 
studies by Holleman et al., which found that animals that 
were given only crystalloids post-scald injury had a higher 
water content in their lungs and recommended the addition 
of  colloids to resuscitation fluid.[116] The view on using col-
loids however, has changed in the last 40 years. Moncrief, 
from the U.S. Army of  Surgical Research, hypothesized that 
the use of  colloid was of  no benefit in the first 24 hours due 
to the disturbed capillary permeability.[117]
In addition to overhydration, Moore et al.,[113] also 
recognized that inhalational lung injury could be exacer-
bated by tracheostomy and mechanical ventilation at high 
oxygen tension. Traditionally, mechanical ventilation is 
acheived using tidal volumes of  10-15 ml per kilogram 
of  body weight which is larger than in normal subjects at 
rest (7-8 ml per kilogram)[118], which can lead to an exces-
sive distension of  the lung leading to disruption of  the 
pulmonary epithelium and endothelium, and the release 
of  inflammatory mediators.[119,120] The use of  lower tidal 
volumes (TV) during ventilation of  patients with acute 
lung injury and acute respiratory distress syndrome has 
been shown by a landmark study by the Acute Respiratory 
Distress Syndrome Network in 2000 to reduce mortality 
by 22% and increase the number of  ventilator-free days. 
There is evidence as well that low TV ventilation protects 
against pulmonary complications in patients without acute 
respiratory distress syndrome.[121] Most burn centers now 
adopt this low TV approach to reduce ventilator-induced 
injury.[122]
Future
The last 50 years has seen a tremendous improvement 
in the advancement of  burn treatment with a significant 
reduction in mortality which can be attributed to the 
developments in early burn excision, early fluid resuscita-
tion, infection control and nutrition. There is still many 
areas in burn care left to explore and improve and here 
we highlight some of  the interesting developments in the 
field of  burn care.
Wound cover with cell therapy
Human keratinocytes can be cultured and are currently 
being used as an adjunct to burn wound healing.[123,124] 
Stem cells have been shown to accelerate burn wound heal-
ing in animal models[125] may prove to revolutionize burn 
care. Early studies with ‘bioprinted’ scaffold incorporat-
ing bone marrow-derived mesenchyme derived stem cells 
and amniotic fluid-derived stem cells showed promising 
results in a wound healing model but these were attributed 
to the growth factors secreted by the stem cells which did 
not become incorporated into the healing tissue.[126] This 
concept however may perhaps help to allay fears regarding 
the use of  pluripotent cells and the potential for malignant 
transformation. Another exciting development in the field 
of  stem cells in wound healing is the concept of  healing 
without scarring as has been demonstrated in early fetal life. 
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Research is currently underway to unlock the molecular 
mechanisms underlying this process with the hope that this 
can be translated into clinical practice.[127]
Pharmalogical and nutritional interventions
Recent advancement in pharmacological interventions 
include the use of  statins, which have demonstrated anti-
inflammatory properties alongside their ability to lower 
serum lipid concentrations. They have been shown to 
improve survival in an animal model of  burns sepsis[128]
and there is some evidence that this benefit translates to 
patients.[129-131]
Systemic administration of  erythropoietin (EPO) has been 
shown to decrease secondary evolution of experimental burn 
injuries[132] and may therefore have a role in minor burns. 
However it has to be noted that recombinant EPO has been 
shown to be ineffective in preventing the anemia that oc-
curs after a major burn injury and does not reduce the need 
for ongoing blood transfusions.[133] This resistance to EPO 
treatment may be due to dampened erythropoiesis and lym-
phopoiesis and enhanced myelopoiesis in the bone marrow 
as demonstrated following burn injury in animal models.[134]
Shock wave therapy
There have been promising early clinical results on the 
use of  shock-wave therapy (ESWT) for healing burn 
wounds.[135,136] Animal studies have demonstrated damp-
ening of  the inflammatory response with a single dose of  
ESWL post-burn[137] and expedition of  healing with mul-
tiple doses[138] as well as improved angiogenesis and blood 
flow along with increased numbers of  rolling and sticking 
leukocytes.[139] A large phase III clinical trial to further evalu-
ate the use of  this treatment modality in burns patients is 
currently underway.
Conclusion
In this article we have highlighted the major advances in the 
evolution of  the care of  burns patients over the past 3500 
years. The advancement of  burn care has been closely as-
sociated with our deeper understanding of  its pathophysiol-
ogy; we have now come to understand the impact that burn 
injuries have in the multiple fields of  current medical science 
i.e. in metabolism and circulation, electrolyte balance and 
nutrition, immunology and infection, inflammation, pulmo-
nary function and wound healing. The major advancement 
in burn care in this century, especially in the last 50 years, is 
a typical example of  the positive feed-back between in-depth 
research and the improvement of  clinical care. It has trans-
formed from the limited attempts to prevent complications 
in the first half  of  the century to the current state of  effective 
shock therapy and surgical interventions which has led to a 
massive increase in the survival of  burn victims. Despite this, 
many challenges still remain and the focus of  burns care in 
the future will be to overcome the problem of burns in the 
elderly, extensive burns, to improve the quality of  the lives 
saved by shortening healing times and therefore lengths of  
hospital stay and to improve scarring. It is hoped that new 
technologies and advances in wound care will achieve wound 
cover with minimal scarring.
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